1.
Miglioretti et al.
The use of computed tomography in pediatrics and the associated radiation exposure and estimated cancer risk.
JAMA Pediatr 2013;167(8):700–7.
2.
Ciet P et al.
Magnetic resonance imaging in children: common problems and possible solutions for lung and airways imaging.
Pediatr Radiol 2015;45(13):1901–15.
3.
Biederer J et al.
MRI of the lung (2/3).
Why...
when ...
how? Insights Imaging 2012;3(4):355–71.
4.
Wild JM et al.
MRI of the lung (1/3): methods.
In sights imaging 2012;345–53.
5.
Stadler A et al.
Artifacts in body MR imaging : their appearance and how to eliminate them.
Eur Radiol 2007;17:1242–55.
6.
Salamon E et al.
Spirometer guided chest imaging in children: It is worth the effort! Pediatr Pulmonol 2017;52(1):48–56.
7.
Scho SO.
Lung MRI at 1.5 and 3 Tesla.
Invest Radiol 2007;42(6):377–83.
8.
Biederer J et al.
MRI of the lung ( 3 / 3 ) — current applications and future perspectives.
Insights Imaging 2012;373–86.
9.
Failo R et al.
Lung morphology assessment using MRI: A robust ultra-short TR/TE 2D steady state free precession sequence used in cystic fibrosis patients.
Magn Reson Med 2009;61(2):299–306.
10.
Johnson KM et al.
Optimized 3D Ultrashort Echo Time Pulmonary MRI.
Magn Reson Med 2013;1250:1241–50.
11.
Cao X et al.
Pulmonary MRI of neonates in the intensive care unit using 3D utrashort echo time and a small foot-print MRI system.
J Magn Reson Imaging 2018;45(2):463–71.
12.
Kerlakian S et al.
Ultrashort Echo-Time Magnetic Resonance Imaging Is a Sensitive Method for the Evaluation of Early Cystic Fibrosis Lung Disease.
Ann Am Thorac Soc 2016;13(11):1923–31.
13.
Dournes G et al.
Lung morphology assessment of cystic fibrosis using MRI with ultra-short echo time at submillimeter spatial resolution.
Eur Radiol 2016;
14.
Grodzki D et al.
Quiet Submillimeter MR Imaging of the Lung Is Feasible with a.
Radiology 2015;276(1).
15.
Grodzki D et al.
Ultrashort Echo Time Imaging Using Pointwise Encoding Time Reduction With Radial Acquisition ( PETRA ).
Magn Reson Med 2012;518:510–8.
16.
Bae K et al.
Comparison of lung imaging using three-dimensional ultrashort echo time and zero echo time sequences : preliminary study.
Eur Radiol 2018;
17.
Ohno Y et al.
Pulmonary High-Resolution Ultrashort TE MR Imaging : Comparison With Computed Tomography for the Assessment of Pulmonary Parenchyma Diseases.
J Magn Reson Imaging 2015;
18.
Romei C et al.
The use of chest magnetic resonance imaging in interstitial lung disease : a systematic review.
Eur Respir Rev 2018;27(150).
19.
Walkup LL et al.
Quantitative Magnetic Resonance Imaging of Bronchopulmonary Dysplasia in the Neonatal Intensive Care Unit Environment.
Am J Resp Crit Care 2015;192:1215–22.
20.
Schwenzer NF et al.
Diagnosing Lung Nodules on Oncologic MR / PET Imaging : Comparison of Fast T1-Weighted Sequences and Influence of Image Acquisition in Inspiration and Expiration Breath-Hold.
KJR 2016;17(5):684–94.
21.
Sommer G et al.
Lung nodule detection in a high-risk population : Comparison of magnetic resonance imaging and low-dose computed tomography.
Eur J Radiol 2014;83(3):600–5.
22.
G.B.Chavan et.
Al.
Steady-State MR Imaging Sequences : Physics ,
Classifica- tion ,
and Clinical.
RadioGraphics 2008;8:1147–61.
23.
Kauczor H.
MRI of the lung: state of the art.
Diagnost Interv Radiol 2012;(November 2011):344–53.
24.
Gieseke J et al.
Initial experience with lung-MRI at 3 .
0 T : Comparison with CT and clinical data in the evaluation of interstitial lung disease activity.
Eur J Radiol 2007;61:256–61.
25.
Hirokawa Y et al.
Evaluation of Motion Correction Effect and Image Quality With the Periodically Rotated Overlapping Parallel Lines With Enhanced Reconstruction and Parallel Imaging Acquisition Technique in the Upper Abdomen.
J Magn Reson Imaging 2008;962:957–62.
26.
Ciet P et al.
Assessment of CF lung disease using motion corrected PROPELLER MRI : a comparison with CT.
Eur Radiol 2015;
27.
Liszewski MC et al.
Magnetic Resonance Imaging o f P e d i a t r i c L u n g P a re n c h y m a ,
A i r w a y s ,
Va s c u l a t u re ,
Ve n t i l a t i o n ,
a n d P e r f u s i o n State of the Art.
Radiol Clin NA 2013;51(4):555–82.
28.
Mu F.
et al.
Assessment of Morphological MRI for Pulmonary Changes in Cystic Fibrosis Patients.
Invest Radiol 2007;42(10):715–25.
29.
Buzan MTA et al.
T2 mapping of CT remodelling patterns in interstitial lung disease.
Eur Radiol 2015;3167–74.
30.
Greil GF et al.
Magnetic Resonance Angiography of Pulmonary and Systemic Venous Anomalies.
J Am Coll Cardiol 2002;39(2).
31.
Lee CU et al.
Establishing a Chest MRI Practice and its Clinical Applications : Our Insight and Protocols.
J Clin Imaging Sci 2014;4(1).
32.
Ciet P et al.
Cine MRI of Tracheal Dynamics in Healthy Volunteers and Patients With Tracheobronchomalacia.
AJR Am J Roentgenol 2017:757–61.
34.
Chen W et al.
Whole-body diffusion-weighted imaging vs .
FDG-PET for the detection of non-small-cell lung cancer .
How do they measure up ? Magn Reson Imaging 2010;28(5):613–20.
35.
Umeoka S et al.
Diffusion-Weighted MRI of Malignant Pleural Mesothelioma: Preliminary Assessment of Apparent Diffusion Coefficient in Histologic Subtypes.
Cardiopulm Imaging 2010:125–30.
36.
Abdel A et al.
Correlation of Apparent Diffusion Coefficient Value With Prognostic Parameters of Lung Cancer.
J Comput Assist Tomogr 2011;35(2):248–52.
37.
Ciet P et al.
Diffusion weighted imaging in cystic fibrosis disease : beyond morphological imaging.
Eur Radiol 2016;11:3030–839.